264 related articles for article (PubMed ID: 28045898)
1. Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.
Zhao C; Isenberg JS; Popel AS
PLoS Comput Biol; 2017 Jan; 13(1):e1005272. PubMed ID: 28045898
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells.
Phelan MW; Forman LW; Perrine SP; Faller DV
J Lab Clin Med; 1998 Dec; 132(6):519-29. PubMed ID: 9851743
[TBL] [Abstract][Full Text] [Related]
4. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF.
Aparicio S; Sawant S; Lara N; Barnstable CJ; Tombran-Tink J
Biochem Biophys Res Commun; 2005 Jan; 326(2):387-94. PubMed ID: 15582590
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary analysis of TSP-1 gene in Plateau zokor (MyospalaxBaileyi) and its expression pattern under hypoxia.
Li S; Xu B; An Z; Wang Z; Li Y; Wei L; Wei D
Cell Mol Biol (Noisy-le-grand); 2019 Mar; 65(3):48-57. PubMed ID: 30942155
[TBL] [Abstract][Full Text] [Related]
6. Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF.
Horiguchi H; Jin L; Ruebel KH; Scheithauer BW; Lloyd RV
Endocrine; 2004 Jul; 24(2):141-6. PubMed ID: 15347840
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-1alpha-dependent expression of thrombospondin-1.
Osada-Oka M; Ikeda T; Akiba S; Sato T
J Cell Biochem; 2008 Aug; 104(5):1918-26. PubMed ID: 18384112
[TBL] [Abstract][Full Text] [Related]
8. Renal Protection Mediated by Hypoxia Inducible Factor-1α Depends on Proangiogenesis Function of miR-21 by Targeting Thrombospondin 1.
Xu X; Song N; Zhang X; Jiao X; Hu J; Liang M; Teng J; Ding X
Transplantation; 2017 Aug; 101(8):1811-1819. PubMed ID: 28737660
[TBL] [Abstract][Full Text] [Related]
9. Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer.
Zhao C; Popel AS
PLoS Comput Biol; 2015 Nov; 11(11):e1004612. PubMed ID: 26588727
[TBL] [Abstract][Full Text] [Related]
10. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.
Zhao C; Isenberg JS; Popel AS
J Cell Mol Med; 2018 Apr; 22(4):2086-2097. PubMed ID: 29441713
[TBL] [Abstract][Full Text] [Related]
11. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development.
Greenaway J; Gentry PA; Feige JJ; LaMarre J; Petrik JJ
Biol Reprod; 2005 May; 72(5):1071-8. PubMed ID: 15616224
[TBL] [Abstract][Full Text] [Related]
13. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
Hyder SM; Liang Y; Wu J; Welbern V
Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
[TBL] [Abstract][Full Text] [Related]
14. The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.
Doçi CL; Zhou G; Lingen MW
Oncogene; 2013 Sep; 32(37):4377-86. PubMed ID: 23085760
[TBL] [Abstract][Full Text] [Related]
15. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
16. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
Bussolati B; Assenzio B; Deregibus MC; Camussi G
J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.
Breitkopf K; Sawitza I; Westhoff JH; Wickert L; Dooley S; Gressner AM
Gut; 2005 May; 54(5):673-81. PubMed ID: 15831915
[TBL] [Abstract][Full Text] [Related]
18. Cell-type specific regulation of thrombospondin-1 expression and its promoter activity by regulatory agents.
Kim SA; Kang JH; Cho I; Bae SW; Hong KJ
Exp Mol Med; 2001 Sep; 33(3):117-23. PubMed ID: 11642546
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.
Smadja DM; d'Audigier C; Bièche I; Evrard S; Mauge L; Dias JV; Labreuche J; Laurendeau I; Marsac B; Dizier B; Wagner-Ballon O; Boisson-Vidal C; Morandi V; Duong-Van-Huyen JP; Bruneval P; Dignat-George F; Emmerich J; Gaussem P
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):551-9. PubMed ID: 21148423
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.
McMorrow JP; Crean D; Gogarty M; Smyth A; Connolly M; Cummins E; Veale D; Fearon U; Tak PP; Fitzgerald O; Murphy EP
Am J Pathol; 2013 Oct; 183(4):1243-1257. PubMed ID: 23933487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
